Denmark· DK-28103322501
Ebixa
A memantine product containing memantinhydrochlorid, registered in Denmark by H. Lundbeck A/S. The same ATC class is registered in 18 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Memantine is registered in 18 of 19 countries.
Countries holding a registration under ATC N06DX01 (memantine), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 11 of them publish a price we can compare per daily dose
Memantine · ATC N06DX01
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of memantine costs, country by country.
Normalised to the WHO defined daily dose (20 mg), the median price runs from $0.22 in United States to $2.93 in Spain — a ×13 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Memantine · price per daily dose (20 mg)
USD · FX 28 Sept 2026
- ES Spain$2.93
- CH Switzerland$2.47
- IT Italy$0.77
- US United States$0.22 (acquisition cost)
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- MEMANTINHYDROCHLORID
- Manufacturer
- H. Lundbeck A/S
- Country
- Denmark (DK)
- ATC code
- N06DX01
- ATC class
- Memantine
- Defined daily dose
- 20 mg, O
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28103322501
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
139 interactions on record for memantine.
Graded by severity as the source publishes them — 42 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Memantine · interactions on record
139 records
- 42 moderate
- 11 minor
- 80 info
Most severe, free to view
- DicycloverineA03AA07moderate
- PropanthelineA03AB05moderate
- MepenzolateA03AB12moderate
- TrospiumA03AB20moderate
6 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under N06DX01
Memantine, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e0dea24e-06f3-4791-a4a9-5f2f582627f6 GET /v1/drugs/e0dea24e-06f3-4791-a4a9-5f2f582627f6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "filmovertrukne tabletter",
"source": "dkma",
"strength": "10 mg",
"auth_role": "MOD",
"dk_drugid": "28103322501",
"substance": "MEMANTINHYDROCHLORID",
"auth_procedure": "Central",
"in_medicinpriser": true,
"registration_date_serial": "37391"
}See everything about memantine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.